Rates, predictors, and causes of readmission after transcatheter aortic valve replacement in patients with chronic kidney disease
- PMID: 39086887
- PMCID: PMC11287458
- DOI: 10.4330/wjc.v16.i7.402
Rates, predictors, and causes of readmission after transcatheter aortic valve replacement in patients with chronic kidney disease
Abstract
Background: Transcatheter aortic valve replacement (TAVR) is a revolutionary procedure for severe aortic stenosis. The coexistence of chronic kidney disease (CKD) and TAVR introduces a challenge that significantly impacts patient outcomes.
Aim: To define readmission rates, predictors, and causes after TAVR procedure in CKD stage 1-4 patients.
Methods: We used the national readmission database 2018 and 2020 to look into readmission rates, causes and predictors after TAVR procedure in patients with CKD stage 1-4.
Results: Out of 24758 who underwent TAVR and had CKD, 7892 (32.4%) patients were readmitted within 90 days, and had higher adjusted odds of being females (adjusted odds ratio: 1.17, 95%CI: 1.02-1.31, P = 0.02) with longer length of hospital stay > 6 days, and more comorbidities including but not limited to diabetes mellitus, anemia, and congestive heart failure (CHF).
Conclusion: Most common causes of readmission included CHF (18.0%), sepsis, and complete atrioventricular block. Controlling readmission predictors with very close follow-up is warranted to prevent such high rate of readmission.
Keywords: Chronic kidney disease; Predictors; Rates; Readmission; Transcatheter aortic valve replacement.
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: We have no financial relationships to disclose.
Figures



Similar articles
-
Incidence, Causes, and Predictors of Early (≤30 Days) and Late Unplanned Hospital Readmissions After Transcatheter Aortic Valve Replacement.JACC Cardiovasc Interv. 2015 Nov;8(13):1748-57. doi: 10.1016/j.jcin.2015.07.022. JACC Cardiovasc Interv. 2015. PMID: 26476610
-
Early readmissions after transcatheter and surgical aortic valve replacement.Catheter Cardiovasc Interv. 2017 Oct 1;90(4):662-670. doi: 10.1002/ccd.26945. Epub 2017 Mar 2. Catheter Cardiovasc Interv. 2017. PMID: 28251807
-
Trends, Predictors, and Outcomes of 30-Day Readmission With Heart Failure After Transcatheter Aortic Valve Replacement: Insights From the US Nationwide Readmission Database.J Am Heart Assoc. 2022 Aug 16;11(16):e024890. doi: 10.1161/JAHA.121.024890. Epub 2022 Aug 5. J Am Heart Assoc. 2022. PMID: 35929464 Free PMC article.
-
Identifying patients likely to be readmitted after transcatheter aortic valve replacement.Heart. 2020 Feb;106(4):256-260. doi: 10.1136/heartjnl-2019-315381. Epub 2019 Oct 24. Heart. 2020. PMID: 31649048 Review.
-
Thirty-day readmissions in surgical and transcatheter aortic valve replacement: A systematic review and meta-analysis.Int J Cardiol. 2018 Oct 1;268:85-91. doi: 10.1016/j.ijcard.2018.05.026. Epub 2018 May 18. Int J Cardiol. 2018. PMID: 29779575
References
-
- Thourani VH, Kodali S, Makkar RR, Herrmann HC, Williams M, Babaliaros V, Smalling R, Lim S, Malaisrie SC, Kapadia S, Szeto WY, Greason KL, Kereiakes D, Ailawadi G, Whisenant BK, Devireddy C, Leipsic J, Hahn RT, Pibarot P, Weissman NJ, Jaber WA, Cohen DJ, Suri R, Tuzcu EM, Svensson LG, Webb JG, Moses JW, Mack MJ, Miller DC, Smith CR, Alu MC, Parvataneni R, D'Agostino RB Jr, Leon MB. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016;387:2218–2225. - PubMed
-
- Writing Committee Members. Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, O'Gara PT, Rigolin VH, Sundt TM 3rd, Thompson A, Toly C. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021;77:e25–e197. - PubMed
-
- Vavilis G, Bäck M, Occhino G, Trevisan M, Bellocco R, Evans M, Lindholm B, Szummer K, Carrero JJ. Kidney Dysfunction and the Risk of Developing Aortic Stenosis. J Am Coll Cardiol. 2019;73:305–314. - PubMed
LinkOut - more resources
Full Text Sources